Product image of Orylmyte (Dermatophagoides Pteronyssinus, Dermatophagoides Farinae) supplied by GNH India

Orylmyte

Active Ingredient:
Dermatophagoides Pteronyssinus, Dermatophagoides Farinae
Origin:
EU

Orylmyte (Dermatophagoides Pteronyssinus, Dermatophagoides Farinae)

Dermatophagoides pteronyssinus and Dermatophagoides farinae, the active ingredients in Orylmyte, are allergen extracts presented as a standardized mixture for diagnostic and therapeutic use in allergy immunotherapy. It is employed primarily for the management of allergic rhinitis and asthma triggered by house dust mite exposure in sensitized individuals.

GNH India supplies Orylmyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stallergenes

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Orylmyte is used in allergen immunotherapy targeting the house‑dust‑mite pathway.

  • Allergic rhinitis: reduces nasal congestion, itching and sneezing in patients sensitized to dust‑mite allergens.
  • Allergic asthma: helps lower bronchial hyper‑responsiveness and frequency of asthma attacks.
  • Atopic dermatitis: may lessen skin inflammation and itching associated with dust‑mite sensitivity.

How It Works

  • Orylmyte contains standardized extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae that stimulate a controlled immune response, promoting the production of blocking IgG antibodies and shifting T‑cell activity from a Th2‑dominant profile toward a regulatory/Th1 profile, thereby reducing allergic inflammation upon natural exposure.

Side Effects

Adverse reactions to Orylmyte are generally related to local or systemic immune activation.

Common Side Effects

  • Injection site redness or swelling.
  • Transient itching or hives at the injection site.
  • Mild fever or malaise.
  • Nasal irritation when administered intranasally.

Serious or Rare Side Effects

  • Anaphylaxis or severe systemic allergic reaction.
  • Persistent asthma exacerbation.
  • Serum sickness‑like reaction.
  • Severe local tissue necrosis.

Precautions & Warnings

When using Orylmyte, clinicians should consider several safety measures.

  • Patient selection: confirm documented IgE sensitization to dust‑mite allergens before initiation.
  • Monitoring: observe patients for at least 30 minutes after the first few administrations for systemic reactions.
  • Concomitant therapy: avoid simultaneous initiation of other allergen immunotherapies.
  • Pregnancy and lactation: use only if the potential benefit justifies the potential risk.
  • Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Orylmyte may interact with other agents that modify immune responses.

Major Interactions (Avoid)

  • Beta‑adrenergic agonists used for acute asthma attacks administered immediately before immunotherapy.
  • High‑dose systemic corticosteroids within 48 hours of dosing.

Moderate Interactions (Monitor Closely)

  • Omalizumab or other anti‑IgE biologics administered within a 2‑week window.
  • Concurrent subcutaneous allergen extracts from different sources.
  • Immunosuppressive agents that could blunt the intended immunologic response.

Frequently Asked Questions

Orylmyte is an allergen extract containing Dermatophagoides pteronyssinus and Dermatophagoides farinae that is used in allergen immunotherapy to treat allergic rhinitis, allergic asthma and atopic dermatitis caused by house‑dust‑mite sensitisation.

The Dermatophagoides extracts in Orylmyte stimulate a controlled immune response that increases blocking IgG antibodies and shifts T‑cell activity away from a Th2‑dominant allergic profile, helping to reduce symptoms when the patient is later exposed to dust‑mite allergens.

The dose of Orylmyte is determined by the prescribing clinician based on the patient’s sensitivity, age, and treatment protocol. Specific dosing regimens are not disclosed publicly and should follow the prescriber’s instructions.

Safety data for Orylmyte in pregnancy or lactation are limited. It should only be used when the potential therapeutic benefit outweighs any possible risk to the mother or infant, and the decision should be made by a qualified healthcare professional.

To order Orylmyte, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Orylmyte provides a standardized mixture of two major house‑dust‑mite species, which may offer broader coverage compared with extracts containing a single species. Clinical choice depends on regional allergen prevalence, regulatory approvals and individual patient response.

Orylmyte should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Do not freeze the product, and follow any additional handling instructions provided by the manufacturer.

Orylmyte is typically administered by subcutaneous injection or intranasal spray according to a physician‑guided immunotherapy schedule. The route and frequency are individualized based on the patient’s treatment plan.

The most serious risks include anaphylaxis, severe asthma exacerbation, and rare systemic reactions such as serum‑sickness‑like illness. Patients should be observed after dosing, and emergency measures must be readily available.

Orylmyte is contraindicated in individuals with a history of severe systemic reactions to dust‑mite extracts, uncontrolled asthma, or those receiving conflicting immunotherapies without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dermatophagoides Pteronyssinus, Dermatophagoides Farinae

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT